Maria Jose Requena Tapia
Overview
Explore the profile of Maria Jose Requena Tapia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lendinez-Cano G, Ojeda-Claro A, Gomez-Gomez E, Morales Jimenez P, Flores Martin J, Dominguez J, et al.
Prostate
. 2021 Jun;
81(12):857-865.
PMID: 34184761
Objectives: This study aimed to externally validate the diagnostic accuracy of the Select MDx test for Significant prostate cancer (Sig PCa) (ISUP > 1), in a contemporaneous, prospective, multicenter cohort...
2.
Rubio Galisteo J, Fernandez L, Gomez Gomez E, de Pedro N, Cano Castineira R, Pedregosa A, et al.
Prostate Cancer Prostatic Dis
. 2020 May;
24(1):88-95.
PMID: 32367011
Background: The objective of this study was to explore telomere-associated variables (TAV) as complementary biomarkers in the early diagnosis of prostate cancer (PCa), analyzing their application in risk models for...
3.
Salguero Segura J, Valero Rosa J, Gomez E, Navarro Cabello M, Ruiz Garcia J, Rodriguez Benot A, et al.
Exp Clin Transplant
. 2020 Feb;
18(2):149-152.
PMID: 32039668
Objectives: Overall, 25% to 33% of patients on kidney transplant wait lists present with prior graft loss. In addition, the number of patients who require a retransplant seems to be...
4.
Gomez Gomez E, Salamanca Bustos J, Carrasco Valiente J, Fernandez Rueda J, Blanca A, Valero Rosa J, et al.
BMJ Open
. 2019 Nov;
9(11):e031032.
PMID: 31722940
Introduction: Risk calculators (RCs) are easy-to-use tools considering available clinical variables that could help to select those patients with risk of prostate cancer (PCa) who should undergo a prostate biopsy....
5.
Frantzi M, Gomez Gomez E, Pedregosa A, Valero Rosa J, Latosinska A, Culig Z, et al.
Br J Cancer
. 2019 May;
120(12):1120-1128.
PMID: 31092909
Background: Prostate cancer progresses slowly when present in low risk forms but can be lethal when it progresses to metastatic disease. A non-invasive test that can detect significant prostate cancer...
6.
Carrasco Valiente J, Ruiz Garcia J, Requena Tapia M
Arch Esp Urol
. 2018 Apr;
71(3):239-246.
PMID: 29633944
Oligometastatic prostate cancer has been proposed as an intermediate stage between localized and extensively disseminated disease. Oligometastatic disease is being diagnosed more frequently due to the advances in imaging tests....
7.
Gomez Gomez E, Valero Rosa J, Carrasco Valiente J, Trivino Tarradas F, Anglada Curado F, Lopez Ruiz D, et al.
Urology
. 2017 Oct;
121:198-199.
PMID: 29074136
Objective: To describe the technique of transrectal biopsy with a new device that fuses multiparametric magnetic resonance (mpMRI) and ultrasound images in real time to guide target biopsies and to...
8.
Arias Vega R, Perula de Torres L, Jimenez Garcia C, Carrasco Valiente J, Requena Tapia M, Cano Castineira R, et al.
Med Clin (Barc)
. 2017 May;
149(9):383-390.
PMID: 28527601
Background And Objective: Renal lithiasis is one of the most important urological diseases. It seems to be related to different socio-demographic and climatic factors, lifestyle and pre-existing comorbidity. The aim...
9.
Carrasco Valiente J, Gomez Gomez E, Requena Tapia M
Arch Esp Urol
. 2017 Feb;
70(1):3-11.
PMID: 28221138
Renal lithiasis is one of the most common disorders in modern society, constituting an important health problem that associates a great economic burden. The nature of stone disease varies according...
10.
Arias Vega M, Perula de Torres L, Carrasco Valiente J, Requena Tapia M, Jimenez Garcia C, Carlos Silva Aycaguer L
Med Clin (Barc)
. 2016 May;
146(12):525-31.
PMID: 27157791
Background And Objective: Urolithiasis is a common urologic condition with increasing incidence in the population worldwide. In Andalusia (Spain), the PreLiRenA study showed a high prevalence (16.4%; 95% confidence interval...